Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JMP Securities Maintains Market Outperform on GH Research, Lowers Price Target to $39

Author: Benzinga Newsdesk | March 01, 2024 12:52pm
JMP Securities analyst Jason Butler maintains GH Research (NASDAQ:GHRS) with a Market Outperform and lowers the price target from $50 to $39.

Posted In: GHRS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist